{"title": "Chromium", "author": null, "url": "https://lpi.oregonstate.edu/mic/minerals/chromium", "hostname": "oregonstate.edu", "description": "Contents Summary Function Possible mechanism of action Nutrient interactions Deficiency The AI Disease Prevention Type 2 diabetes mellitus Cardiovascular disease Health claims D", "sitename": "Linus Pauling Institute", "date": "2014-04-22", "cleaned_text": "1. Vaidyanathan VG, Asthana Y, Nair BU. Importance of ligand structure in DNA/protein binding, mutagenicity, excision repair and nutritional aspects of chromium(III) complexes. Dalton Trans. 2013;42(7):2337-2346. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/23247426) 2. Agostoni C, Canani RB, Fairweather-Tait S, et al. Scientific Opinion on Dietary Reference Values for chromium. EFSA J. 2014;12(10):3845. 3. Vincent JB. New evidence against chromium as an essential trace element. J Nutr. 2017;147(12):2212-2219. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/29021369) 4. United States Environmental Protection Agency. Chromium compounds; 2000. 5. Food and Nutrition Board, Institute of Medicine. Chromium. Dietary reference intakes for vitamin A, vitamin K, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington 2001:197-223. [(National Press)](https://nap.nationalacademies.org/read/10026/chapter/8) Stoecker M, Shike M, Ross A, Caballero B, Cousins R, eds. Modern Nutrition in Health and Disease. Philadelphia: Lippincott, Williams & Wilkins; 2006:332-337. 8. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414(6865):799-806. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/11742412/) 9. Martin-Timon I, Sevillano-Collantes C, Segura-Galindo A, Del Canizo-Gomez FJ. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes. 2014;5(4):444-470. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/25126392) 10. Hua Y, Clark S, Ren J, Sreejayan N. Molecular mechanisms of chromium in alleviating insulin resistance. J Nutr Biochem. 2012;23(4):313-319. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/22423897) chromium-binding Biochem. 2021;223:111555. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/34315118) 12. Nair S. Metabolic of chromium \u2014 Potential molecular mechanisms. In: Vincent JB, ed. The Nutritional Biochemistry of Chromium (III). Second edition; Elsevier; 2019:175-191. 13. Wang ZQ, Yu Y, Zhang XH, Komorowski J. Chromium-insulin reduces insulin clearance and enhances insulin signaling by suppressing hepatic insulin-degrading enzyme and proteasome protein expression in (Lausanne). 2014;5:99. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/25071716) 14. Vincent A, Sigel H, Sigel eds. Ions and Human Diseases: Springer Science+Business Media Dordrecht; 2013:171-198. 15. WW, Evans WJ. Chromium picolinate by older men: DB. Chromium supplementation and resistance training: effects on body composition, strength, and trace element status of men. Am J Clin Nutr. 1996;63(6):954-965. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/8644693/) picolinate supplementation in women: effects on body weight, composition, and iron status. Nutrition. 2007;23(3):187-195. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/17291720) 18. Rech M, To L, Tovbin A, Smoot T, Mlynarek M. Heavy metal in the intensive care unit: a review of current literature on trace element supplementation in critically ill patients. Nutr Clin Pract. 2014;29(1):78-89. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/24336443) 19. Jeejeebhoy KN. The role of chromium in nutrition and therapeutics and as a potential toxin. Nutr Rev. 1999;57(11):329-335. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/10628183/) 20. Lukaski HC. Magnesium, zinc, J Clin Nutr. 2000;72(2 Suppl):585S-593S. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/10919964/) 21. Rubin MA, Miller JP, Ryan AS, et al. Acute and chronic resistive exercise increase urinary chromium excretion in men as measured with an enriched chromium stable isotope. J Nutr. 1998;128(1):73-78. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/9430605/) 22. US Department of Health and Human Services. Nutrient Assessment for DRI Review. 8/24/2021. Available at: [https://health.gov/our-work/nutrition-physical-activity/dietary-guidelines/dietary-reference-intakes-dris/nutrient-assessment-dri-review](https://health.gov/our-work/nutrition-physical-activity/dietary-guidelines/dietary-reference-intakes-dris/nutrient-assessment-dri-review). Accessed 12/9/2022. 23. Mertz W. review. J Nutr. 1993;123(4):626-633. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/8463863/) 24. Rao SS, Disraeli P, McGregor T. Impaired glucose tolerance and impaired fasting glucose. Am Fam Physician. 2004;69(8):1961-1968. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/15117017) 25. Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes. 2003;52(12):2867-2873. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/14633845) 26. Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279-2290. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/22683128) 27. Ali A, Ma Y, Reynolds J, Wise JP, Sr., Inzucchi SE, Katz DL. Chromium effects on glucose tolerance and insulin sensitivity in persons at risk for diabetes mellitus. Endocr Pract. 2011;17(1):16-25. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/20634174) 28. Masharani U, et al. Chromium supplementation in non-obese non-diabetic subjects is associated with a decline in insulin sensitivity. BMC Endocr Disord. 2012;12:31. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/23194380) 29. Bailey CH. Improved meta-analytic methods show no effect of chromium supplements on fasting glucose. Biol Trace Elem Res. 2014;157(1):1-8. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/24293356) 30. Kobla HV, Volpe SL. Chromium, Crit Food Sci Nutr. 2000;40(4):291-308. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/10943591/) 31. Ghanbari M, Amini MR, Djafarian K, S. The effects of chromium supplementation on blood pressure: a systematic review and meta-analysis of randomized clinical trials. Eur J Clin Nutr. 2022;76(3):340-349. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/34302131) 32. Zhang X, Cui L, Chen B, et al. Effect of chromium supplementation on hs-CRP, TNF-alpha and IL-6 as risk factor for [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/33321447) 33. Vincent JB. The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent. Sports Med. 2003;33(3):213-230. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/12656641) 34. Federal Trade Commission. United States of American Before Federal Trade Commission. Available at: [https://www.ftc.gov/sites/default/files/documents/cases/1997/07/nutrit2.htm](https://www.ftc.gov/sites/default/files/documents/cases/1997/07/nutrit2.htm). Accessed 12/8/2022. 35. US Food & Drug Administration. Qualified health claims: letters of denial. Available at: [https://www.fda.gov/food/food-labeling-nutrition/qualified-health-claims-letters-denial](https://www.fda.gov/food/food-labeling-nutrition/qualified-health-claims-letters-denial). Accessed 12/8/2022. 36. Federal Trade Commission. Companies advertising popular dietary supplement \"chromium picolinate\" can't substantiate weight loss and health benefit claims, says FTC; 1996. Available at: [https://www.ftc.gov/news-events/news/press-releases/1996/11/companies-advertising-popular-dietary-supplement-chromium-picolinate-cant-substantiate-weight-loss](https://www.ftc.gov/news-events/news/press-releases/1996/11/companies-advertising-popular-dietary-supplement-chromium-picolinate-cant-substantiate-weight-loss). Accessed 9/23/2014. 37. Onakpoya I, Posadzki P, Ernst E. Chromium supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials. Obes Rev. 2013;14(6):496-507. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/23495911) 38. Wing RR, Pinto AM, Crane MM, Kumar R, Weinberg BM, Gorin AA. A statewide intervention reduces BMI in adults: Shape Up Rhode Island results. Obesity (Silver Spring). 2009;17(5):991-995. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/19180068) 39. Tsang C, Taghizadeh M, Aghabagheri E, Asemi Z, Jafarnejad S. A meta-analysis of the effect of chromium supplementation on anthropometric indices of subjects with overweight or obesity. Clin Obes. 2019;9(4):e12313. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/31115179) 40. Anton SD, Morrison CD, Cefalu WT, et al. Effects of chromium picolinate on food and satiety. Diabetes Technol Ther. 2008;10(5):405-412. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/18715218) 41. Brownley KA, Von Holle A, RM, La Via M, Bulik CM. A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study. J Psychosom Res. 2013;75(1):36-42. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/23751236) 42. Tian H, Guo X, Wang X, et al. Chromium picolinate supplementation for overweight or obese adults. Cochrane Database Syst Rev. 2013;11:CD010063. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/24293292) 43. US Department of Health and Human Services. Qualified Health Claims: Letter of Enforcement Discretion - Chromium Picolinate and Insulin Resistance(Docket No. 2004Q-0144). http://wayback.archive-it.org/7993/20171114183739/https:/www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm073017.htm. Accessed 11/14/2017. BW, MacNeil S, Hardisty CA, Heller S, Burgin C, Gray TA. Chromium homeostasis in patients with type II (NIDDM) diabetes. J Trace Elem Med Biol. 1999;13(1-2):57-61. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/10445219/) 45. Hellerstein MK. type II diabetes? Nutr Rev. 1998;56(10):302-306. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/9810809/) 46. Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997;46(11):1786-1791. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/9356027/) 47. Althuis MD, Jordan NE, Ludington EA, Wittes JT. Glucose and insulin responses to meta-analysis. Am J A, Nikfar S, Seyedifar M. Effect of chromium on glucose and lipid profiles in patients with type 2 diabetes; a meta-analysis review of randomized trials. et al. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2020;161:105098. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/32730903) 50. Zhao F, Pan D, Wang N, et al. Effect of chromium supplementation on blood glucose and lipid levels in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Biol Trace Elem Res. 2022;200(2):516-525. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/33783683) 51. Yin RV, Phung OJ. Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus. Nutr J. 2015;14:14. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/25971249/) 52. Costello RB, Dwyer JT, Bailey RL. Chromium supplements for glycemic control in type 2 diabetes: limited evidence of effectiveness. Nutr Rev. 2016;74(7):455-468. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/27261273) 53. US Preventive Services Task Force, Davidson KW, Barry MJ, et al. Screening for gestational diabetes: US Preventive Services Task Force recommendation statement. JAMA. 2021;326(6):531-538. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/34374716) 54. American Diabetes Association. Gestational Suppl 1:S88-90. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/14693936) 56. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773-1779. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/19465232) 57. Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B. Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes. Diabetes Care. 2008;31(10):2026-2031. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/18628572) 58. Gunton JE, Hams G, Hitchman R, McElduff A. Serum chromium does not predict glucose tolerance in late pregnancy. Am J Clin Nutr. 2001;73(1):99-104. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/11124757/) 59. Woods SE, Ghodsi V, Engel A, Miller J, James S. Serum chromium and gestational diabetes. J Am Board Fam Med. 2008;21(2):153-157. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/18343864) 60. Jovanovic-Peterson L, Peterson CM. Vitamin and mineral deficiencies which may predispose to glucose intolerance of pregnancy. J Am Coll Nutr. 1996;15(1):14-20. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/8632110/) 61. Bai J, Xun P, Morris S, Jacobs DR, Jr., Liu K, He K. Chromium exposure and incidence of metabolic syndrome among American young adults over a 23-year follow-up: the CARDIA Trace Element Study. Sci Rep. 2015;5:15606. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/26489690) 62. Chen S, Zhou L, Guo Q, et al. Association of plasma chromium with metabolic syndrome among Chinese adults: a case-control study. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/32967680) 63. Rosolova H, Krizek M, et al. Chromium supplementation reduces resting heart rate in patients with metabolic syndrome and impaired glucose tolerance. Biol Trace Elem Res. 2018;183(2):192-199. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/28856601) 64. Deswal R, Narwal Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020;13(4):261-271. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/33627974) 65. Lentscher JA, Decherney AH. Clinical Obstet Gynecol. 2021;64(1):3-11. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/32701517) 66. R. Chromium supplementation and polycystic ovary syndrome: A systematic Med Biol. 2017;42:92-96. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/28595797) 67. Tang XL, Sun Z, L. Chromium supplementation in women with polycystic ovary syndrome: 68. Heshmati J, R, Vesali S, et al. The effects of supplementation with chromium on insulin resistance indices in women with polycystic ovarian syndrome: a systematic review and meta-analysis of A, Alizadeh M. Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: systematic review. Nutr Res. 2018;56:1-10. Chromium 1992;32:9-18. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/1375091) 71. Kozlovsky PB, Reiser S, Anderson RA. Effects of diets high in simple sugars on urinary chromium losses. Metabolism. 1986;35(6):515-518. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/3713513) 72. Anderson RA, Bryden NA, Polansky MM. Dietary chromium intake. Freely chosen diets, institutional diet, and individual foods. Biol Trace Elem Res. 1992;32:117-121. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/1375047/) 73. US Department of Health and Human Services, National Institutes of Health, Office of Dietary Supplements. Dietary Supplement Label Database (DSLD). [Internet]. Available at: Available from: [https://dsld.nlm.nih.gov/dsld/](https://dsld.nlm.nih.gov/dsld/.). N, Kottwitz K, Freund B, Dresow B, Fischer R, Nielsen P. Bioavailability of chromium(III)-supplements in rats and humans. Biometals. 2012;25(5):1051-1060. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/22814636) 75. Loomis D, Guha N, Hall AL, Straif K. Identifying occupational carcinogens: an from the IARC [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/29769352) 76. Nielsen boron, chromium, and other trace elements. In: Erdman JJ, Macdonald I, Zelssel S, eds. Present Knowledge of Nutrition: John Wiley & Sons, Inc.; 2012. 77. Blasiak J, Kowalik J. A comparison of the in vitro genotoxicity of tri- and hexavalent chromium. Mutat Res. Speetjens JK, Collins Woski SA. The nutritional chromium(III) tris(picolinate) cleaves DNA. Chem Res Toxicol. 1999;12(6):483-487. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/10368310/) 79. Wise JP, Sr., Patierno SR, Wetterhahn KE. Chromium(III) picolinate produces chromosome hamster ovary cells. FASEB J. 1995;9(15):1643-1648. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/8529845/) 80. Jiang L, Vincent JB, Bailey MM. [Cr(3)O(O(2)CCH(2)CH(3))(6)(H(2)O)(3)]NO(3).H(2)O (Cr3) toxicity potential in bacterial and mammalian cells. Biol Trace Elem Res. 2018;183(2):342-350. [(PubMed)](https://www.ncbi.nlm.nih.gov/pubmed/28879636) 81. Kato I, Vogelman JH, Dilman V, et al. Effect of supplementation with chromium picolinate on antibody titers to [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/9794131/) 82. Hathcock JN. J Wasser WG, Feldman renal failure after ingestion of over-the-counter chromium picolinate. Ann Intern Med. 1997;126(5):410. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/9054292/) Gauthier S, Weskamp C, Marple J, Spry L. Acute tubular necrosis associated with chromium picolinate-containing dietary supplement. Ann Pharmacother. 2006;40(3):563-566. [(PubMed)](https://pubmed.ncbi.nlm.nih.gov/16492795/) 86. Davies S, McLaren Howard J, Hunnisett A, Howard M. Age-related decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients--implications for the prevention of cardiovascular disease and type "}